| Literature DB >> 28344771 |
Margarita Malakyan1, Nelly Babayan2, Ruzanna Grigoryan3, Natalya Sarkisyan3, Vahan Tonoyan1, Davit Tadevosyan1, Vladimir Matosyan1, Rouben Aroutiounian4, Arsen Arakelyan3.
Abstract
Schiff bases and theirEntities:
Keywords: HeLa; KCL-22; L-tryptophan; Schiff base; copper (II) complex; cytotoxicity; synthesis
Year: 2016 PMID: 28344771 PMCID: PMC5333612 DOI: 10.12688/f1000research.9226.1
Source DB: PubMed Journal: F1000Res ISSN: 2046-1402
The elemental analysis of synthesized Schiff bases.
| Schiff base | K, % | C, % | H, % | N, % | ||||
|---|---|---|---|---|---|---|---|---|
| Calculated | Observed | Calculated | Observed | Calculated | Observed | Calculated | Observed | |
| K.2pyr.Trp | 11.80 | 11.62 | 61.61 | 61.88 | 4.26 | 4.63 | 12.68 | 12. 53 |
| K.3pyr.Trp | 11.80 | 11.58 | 61.61 | 61.79 | 4.26 | 4.52 | 12.68 | 12.93 |
| K.4pyr.Trp | 11.80 | 11.67 | 61.61 | 61.92 | 4.26 | 4.58 | 12.68 | 12.85 |
Figure 1. Suggested structure of the 2pyr.Trp ( A), 3pyr.Trp ( B) and 4pyr.Trp ( C) Schiff bases.
The IR absorbance spectra of Schiff bases derived from L-tryptophan and their copper complexes.
| Valence deviations | Schiff bases | Metallocomplexes |
|---|---|---|
| ν (NH), cm -1 | 3180 – 3190 | 3250 – 3270 |
| ν (C=N), cm -1 | 1625 – 1645 | 1611 – 1625 |
| ν (C=О), cm -1 | 1583 – 1595 | |
| ν (C-N), cm -1 | 1080 – 1088 | 1060 – 1080 |
| ν (C-O), cm -1 | 1103 – 1109 | 1106 – 1109 |
| ν (C-N), cm -1 | 1080 – 1088 | 1060 – 1080 |
| ν (C-C), cm -1 | 1013 – 1016 | 1013 – 1020 |
Elemental analysis of Cu-2pyr.Trp, Cu-3pyr.Trp and Cu-4pyr.Trp metallocomplexes.
| Cu(II)
| C, % | H, % | Cu, % | N, % | ||||
|---|---|---|---|---|---|---|---|---|
| Calculated | Observed | Calculated | Observed | Calculated | Observed | Calculated | Observed | |
| Cu-2pyr.Trp | 63.00 | 63.28 | 4.35 | 4.76 | 9.80 | 9.34 | 12.97 | 12.81 |
| Cu-3pyr.Trp | 63.00 | 63.48 | 4.35 | 4.81 | 9.80 | 10.31 | 12.97 | 13.19 |
| Cu-4pyr.Trp | 63.00 | 62.67 | 4.36 | 4.64 | 9.80 | 10.33 | 12.97 | 12.62 |
Figure 2. Suggested structure of Cu-2pyr.Trp ( A), Cu-3pyr.Trp ( B), Cu-4pyr.Trp ( C) metallocomplexes.
Figure 3. The cytotoxicity of 2pyr.Trp ( A) and Cu-2pyr.Trp ( B) in HeLa and KCL-22 cell lines. Dose-response curves were obtained after 48 hours of treatment with Schiff base 2pyr.Trp and its copper(II) complex Cu-2pyr.Trp at the concentration range of 0.1–1000 µM/mL. Cell viability was expressed as a percentage of the negative control (cell cultures with no treatment). Doses inducing 50% inhibition of cell viability (the IC 50 value) were calculated to determine the cytotoxicity of 2pyr.Trp and Cu-2pyr.Trp. The IC 50 value estimated for 2pyr.Trp in KCL-22 cell line was equal to 56±9.1 μM/mL, whereas the viability of HeLa cells was more than 90% at the highest concentration tested ( A). The IC 50 values estimated for Cu-2pyr.Trp were equal to 7±1.7 μM/mL and 80±7.5 μM/mL for HeLa and KCL-22 cell lines, respectively ( B).
Figure 4. The cytotoxicity of 3pyr.Trp ( A) and Cu-3pyr.Trp ( B) in HeLa and KCL-22 cell lines. Dose-response curves were obtained after 48 hours of treatment with Schiff base 3pyr.Trp and its copper(II) complex Cu-3pyr.Trp at the concentration range of 0.1–1000 µM/mL. Cell viability was expressed as a percentage of the negative control (cell cultures with no treatment). Doses inducing 50% inhibition of cell viability (the IC 50 value) were calculated to determine the cytotoxicity of 3pyr.Trp and Cu-3pyr.Trp. The non-cytotoxic profile was observed for 3pyr.Trp in both cell lines, since the viability of HeLa and KCL-22 cells was around 100% at the highest concentration tested ( A). The Cu-3pyr.Trp demonstrated the increased cytotoxic activity against both cell lines, however, the IC 50 value was possible to estimate only for HeLa cells (500±5.6 μM/mL), since the viability of KCL-22 cells was more than 60% at the highest concentration tested ( B).
Figure 5. The cytotoxicity of 4pyr.Trp ( A) and Cu-4pyr.Trp ( B) in HeLa and KCL-22 cell lines. Dose-response curves were obtained after 48 hours of treatment with Schiff base 4pyr.Trp and its copper(II) complex Cu-4pyr.Trp at the concentration range of 0.1–1000 µM/mL. Cell viability was expressed as a percentage of the negative control (cell cultures with no treatment). Doses inducing 50% inhibition of cell viability (the IC 50 value) were calculated to determine the cytotoxicity of 4pyr.Trp and Cu-4pyr.Trp. The IC 50 value estimated for 4pyr.Trp in KCL-22 cell line was equal to 100±6.5 μM/mL, whereas the viability of HeLa cells was more than 60% at the highest concentration tested ( A). The IC 50 values estimated for Cu-4pyr.Trp were equal to 10±5 μM/mL and 30±3.8 μM/mL for HeLa and KCL-22 cell lines, respectively ( B).
The cytotoxicity (expressed as IC 50, μM/mL) of tested compounds in HeLa and KCL-22 cells.
| Cells lines | L-tryptophan Schiff bases and their copper(II) complexes | |||||
|---|---|---|---|---|---|---|
| 2pyr.Trp | 3pyr.Trp | 4pyr.Trp | Cu-2pyr.Trp | Cu-3pyr.Trp | Cu-4pyr.Trp | |
| HeLa | > 1000 | > 1000 | > 1000 | 7±1.7 | 500±5.6 | 10±5 |
| KCL-22 | 56±9.1 | > 1000 | 100±6.5 | 80±7.5 | >1000 | 30±3.8 |
|
| >4000 | >5000 | >5000 | >2000 | >5000 | >2000 |
|
| Class III
| Class IV
| Class IV
| Class III
| Class IV
| Class III
|
Figure 6. Comparison of Schiff bases and copper(II) complexes cytotoxicity in HeLa and KCL-22 cell lines.
*p<0.01.